Narrativa: The Agentic AI That Turns Regulatory Chaos into Submission-Ready, MLR-Approved Content

Overview: How Narrativa’s AI‑Driven Regulatory & MLR Review Platform Transforms Life Sciences Documentation Workflows

Narrativa is an AI‑driven platform that streamlines regulatory and medical‑legal‑regulatory (MLR) content review, regulatory submission assembly and quality control, and claims and labelling consistency checks across life sciences documentation. It addresses persistent bottlenecks created by manual review processes, fragmented authoring workflows, and the growing volume of promotional, scientific, and regulatory content that must be checked for accuracy, consistency, and submission readiness. By bringing these activities into a unified, AI‑assisted environment, Narrativa helps teams reduce rework, minimise delays, and improve the overall quality of documentation moving through complex review cycles.

Narrativa is an agentic AI platform for life-sciences teams that supports regulatory and medical writing workflows across document generation, review, validation, and submission preparation. Within the Regulatory Automation – Document Review and Authoring category, it helps teams create, assess, and manage complex clinical and regulatory content, including clinical study reports, patient narratives, protocols, investigator brochures, safety and efficacy summaries, and documents prepared for eCTD submissions.

As a medical writing efficiency solution, Narrativa combines AI-assisted drafting and content adaptation with automated checks against approved source data, predefined requirements, related documents, and controlled terminology. Its platform can identify potential inaccuracies, inconsistencies, missing information, unsupported statements, and cross-document discrepancies before content moves through review—reducing repetitive manual checks and allowing medical writers, regulatory professionals, and subject-matter experts to focus on scientific judgement and final approval.

Narrativa’s agentic workflows can extract and interpret information from clinical data, tables, listings, and figures; generate structured first drafts; reuse and reformat approved content; manage cross-references and version changes; and present validation findings for expert review. The platform supports traceability by linking content and review findings to relevant source material, while role-based workflows, audit trails, and human oversight remain key parts of a controlled, regulated-content process.

At a high level, Narrativa applies natural language processing and machine learning to analyse large volumes of text and structured content, identify potential inconsistencies or gaps, and surface issues that typically require multiple rounds of manual review to detect.  The platform can assess regulatory content against approved source data, predefined requirements, and related documents, highlighting potential inconsistencies, missing information, unsupported statements, and content that requires expert review. This AI‑assisted review shifts teams from line‑by‑line manual checks to exception‑based oversight, where human experts focus on higher‑value judgment rather than repetitive verification tasks.

For healthcare organisations, the impact is most visible in shortened review and submission timelines, reduced administrative burden on medical, regulatory, and writing teams, and more reliable documentation quality across markets and product lines. Narrativa can help accelerate the path from draft content to submission‑ready or MLR‑approved materials, lowering the risk of late‑stage findings that force teams to rework sections under time pressure. In doing so, it supports more predictable workflows, clearer decision‑making, and better use of specialised expertise, as subject matter experts spend more time evaluating content and less time searching for inconsistencies or formatting issues.

Last checked on 23 May 2026: Narrativa highlights its evolution into an agentic AI platform for life sciences, reporting that it generated 65,000 regulatory compliance documents for pharma customers in 2025.

What is Narrativa?

Narrativa is an agentic AI platform that generates, assembles, and quality‑checks complex clinical, regulatory, and commercialisation documentation for life sciences organisations, with primary use cases in regulatory submission drafting, MLR and promotional content review, and compliance documentation workflows. Pharmaceutical, biotech, and other life sciences companies and their regulatory, medical writing, and commercialisation teams use it, not frontline clinicians or hospitals directly.

Narrativa stands out for its specialised life‑sciences–focused AI agents, its use at scale to produce tens of thousands of regulatory documents, and its documented emphasis on responsible, auditable AI with governance practices tailored to highly regulated environments.

Why Do Leading Healthcare Teams Trust Narrativa?

• Narrativa has a strategic partnership with Asphalion, a specialist regulatory consultancy for life sciences, focused on delivering customised AI solutions for complex regulatory and compliance workflows.

• Narrativa positions its platform specifically for life sciences and healthcare, indicating sector focus rather than a generic horizontal AI offering.

• The company publicly aligns its AI governance with ISO 42001, the emerging international standard for trustworthy AI, and describes applying this framework to life sciences documentation use cases.

• Narrativa emphasizes AI governance practices spanning data sourcing, model training, deployment, and monitoring, aimed at meeting stringent healthcare and regulatory expectations.

• The platform reports production use at scale, with more than 65,000 regulatory compliance documents generated for pharmaceutical customers in 2025, indicating operational maturity and sustained demand.

• Narrativa explicitly frames its solutions around compliance with healthcare and regulatory standards, including GxP expectations for documentation processes.

• The company publicly discusses alignment with evolving FDA and EMA principles for AI in regulatory submissions, indicating awareness of and responsiveness to current regulatory thinking.

• Narrativa engages with academic and industry audiences on AI in life sciences (e.g., thought leadership on AI trends in pharma and ethical, transparent AI), which supports credibility with cautious enterprise buyers.